MEG3 and cholangiocarcinoma: In cholangiocarcinoma and gallbladder cancer, MEG3 stimulated NF-κB signaling pathway and triggered apoptosis by sponging miR-361-5p expression and activating TNF receptor-associated factor 3 (TRAF3) [101,102].